top of page

ASCO 2021 Guide For Smid-Cap Biotech Investors

Updated: Jun 3, 2021

(Last updated 5/20/21: To view our updated version of this ASCO21 Guide (5/27/21) click here)

The American Society of Clinical Oncology (ASCO) 2021 Annual meeting offers a lot of opportunity for biotech and biopharma investors. The abstract release and especially the presentations often act as major catalyst events for a number of biotech stocks. If you are a small or mid-cap biopharma investor, is your hub for ASCO21.

Key ASCO dates

As of 5/20/21, we have identified 47 companies in our database of over 550 smid-cap biotech companies, that are presenting clinical trial updates at ASCO 2021. See the table below for our initial list from 5/18. Since then, we have updated this list to include more companies. Our team continues to scour information from smid-cap biopharma companies to identify additional companies who are presenting clinical data updates at ASCO21.

ASCO21 abstracts were released on 5/19/21. We have included information about the percent stock move the day after the abstract release, as well as abstract summaries for the biggest positive movers, in our ASCO21 Investor Hub forum post here on Our ASCO21 Investor Hub forum post has more information regarding the ASCO21 clinical trial update presentations from small and mid-cap biopharma companies. Furthermore, in our ASCO21 Investor Hub full forum post on we will update our list below as we find more companies presenting clinical trial updates at ASCO and as we continue to analyze the abstracts. In addition, our ASCO21 Investor Hub forum post has our Big-Mover analysis, which we've started to put together. For this analysis we seek to identify those presentations that are most likely to move the underlying stock by at least 15% up or down. Finally, you can use our database to learn more about any of the drug candidates in these presentations, including mechanism of action, drug history, and more! We plan to update our database with the ASCO posters as they become available. Click here to try 30-days risk-free for full access to our full ASCO21 Investor Hub forum post and our database of information about these drug candidates.


The table below is our initial 5/18/21 table that outlines the stock ticker, drug, and indication being presented at ASCO21

(See our ASCO21 Investor Hub forum post for a more updated list of smid-cap companies presenting clinical trial updates at ASCO21):

ASCO '21 Smid-Cap Abstract Events:

For details about the ASCO '21 presentation, drug history, and potential big movers, try out BPIQ for 30 days risk-free. Learn more here


ASC) '21 Abstract Event Table as Image:

ASCO 2021 biotech abstract events. Small-mid cap biopharma stocks that are investable across ASCO
ASCO 2021 Biotech Investor Events

bottom of page